Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Taki who wrote (130399)	3/29/2004 12:28:19 PM
From: Taki	Read Replies (1) \| Respond to of 150070

GBLL .022x.023.Ready to take off?Level ii looks good.

To: Taki who wrote (130399)	3/29/2004 4:28:43 PM
From: Taki	Read Replies (1) \| Respond to of 150070

DNAP.046.Nice close.Let us not forget CC April 1st this Thursday. (PR NEWSWIRE) DNAPrint(TM) Participates in the TBTF and BioFlorida Tampa Bay Pa DNAPrint(TM) Participates in the TBTF and BioFlorida Tampa Bay Partnering Confer said Tony Frudakis, PhD. "We're excited about the partnering opportunities that might exist in our own backyard." SARASOTA, Fla., March 17 /PRNewswire-FirstCall/ -- DNAPrint's CEO and President is presenting at the combined Tampa Bay Technology Forum and BioFlorida Tampa Bay partnering conference on April 1, 2004 at the Hyatt Sarasota, 1000 Blvd. of the Arts, Sarasota, Florida. The presentation will include a description of DNAPrint(TM)'s technology and market applications. The presentation will highlight the four market segments in which DNAPrint(TM) applies its proprietary Single Nucleotide Polymorphism (SNP) screening technology: 1) genealogy; featuring its latest released product ANCESTRYbyDNA(TM) 2.5 used by genealogists and families to help understand their genetic heritage; 2) forensics; featuring its flagship product DNAWitness(TM) 2.0, which was introduced and first used in the first quarter of 2003 and has since helped detectives and investigators in two high-profile cases, the Louisiana serial killer case (2003) and the Concord, California case; 3) pharmacogenomics; the company is working with a Florida institution to advance its technology (known as Ovanome(TM)) and to combine its technology with other genetic methods to help reduce the risk of cancer treatment; and 4) contract genotyping; the company has developed a strong reputation as a reliable and cost-effective contract genotyping service and continues to supply medical centers and universities with this service. "We see the forum as a means to advance our company and improve shareholder value through partnering opportunities that might present themselves at this conference," said Richard Gabriel, CEO and President of DNAPrint(TM) genomics, Inc. "Over the last year we have been relatively quiet. We have spent this time reorganizing the company and advancing our technologies. We are seeking partners in all three commercial areas, genealogy, forensics and pharmacogenomics, and that could include partners in a variety of structures. We have just finished an $8.0 million financing round, and the proceeds from that transaction have been flowing into the company at a steady rate. This is the fuel that we need to build the business and advance the technology, and we are doing that." "The company's senior management will continue to explore all opportunities, and we believe these partnering forums are a great vehicle for allowing companies to exchange ideas and seek new opportunities," said Hector Gomez, MD, PhD, Chairman of the Board and Chief Medical Officer. "Our joining BioFlorida and being involved with the Sarasota business community is another step in advancing our technology and company," he said. "Sarasota and the Tampa Bay area are a rapidly emerging biotechnology center, and we were one of the first life-science companies to start up in Sarasota -- well, certainly one of the first genetics companies," said Tony Frudakis, PhD. "We're excited about the partnering opportunities that might exist in our own backyard."